---
schema_version: "secwatch.filing_event.v1"
accession: "0001842952-25-000024"
form_type: "8-K"
ticker: "CNTX"
cik: "0001842952"
company_name: "Context Therapeutics Inc."
filed_at: "2025-02-28T23:59:59+00:00"
generated_at: "2026-05-26T00:02:42.471429+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Context Therapeutics receives Nasdaq minimum bid price deficiency notice

## Summary
- Received Nasdaq deficiency notice on Feb 27, 2025 for failing $1.00 minimum bid price for 30 consecutive business days.
- Initial 180-day cure period runs until August 26, 2025 to regain compliance.
- Must have closing bid price of $1.00+ for at least 10 consecutive business days to cure.
- Company will monitor and evaluate options, but no assurance of regaining compliance.
- If not cured by Aug 26, may be eligible for an additional 180-day grace period.

## SEC filing metadata
- accession: 0001842952-25-000024
- form_type: 8-K
- ticker: CNTX
- cik: 0001842952
- company_name: Context Therapeutics Inc.
- filed_at: 2025-02-28T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842952/000184295225000024/0001842952-25-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842952/000184295225000024/cntx-20250227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001842952-25-000024
- JSON: https://secwatch.observer/filing/0001842952-25-000024.json
- Plain text: https://secwatch.observer/filing/0001842952-25-000024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.